MX2010001363A - Peptidos inmunomoduladores. - Google Patents
Peptidos inmunomoduladores.Info
- Publication number
- MX2010001363A MX2010001363A MX2010001363A MX2010001363A MX2010001363A MX 2010001363 A MX2010001363 A MX 2010001363A MX 2010001363 A MX2010001363 A MX 2010001363A MX 2010001363 A MX2010001363 A MX 2010001363A MX 2010001363 A MX2010001363 A MX 2010001363A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- peptides
- relates
- immunomodulatory peptides
- fcrn
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere a péptidos derivatizados con un polímero hidrófilo que, en algunas modalidades, se unen a FcRn humano e inhiben la unión de la región Fc de una IgG a un FcRn, modulando de este modo los niveles en suero de IgG. Las composiciones y métodos descritos se pueden usar en algunas modalidades, por ejemplo, al tratar enfermedades autoinmunitarias y trastornos inflamatorios. La invención también se refiere, en modalidades adicionales, a métodos para usar, y métodos para producir, los péptidos de la invención.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95496807P | 2007-08-09 | 2007-08-09 | |
PCT/US2008/071960 WO2009020867A2 (en) | 2007-08-09 | 2008-08-01 | Immunomodulatory peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010001363A true MX2010001363A (es) | 2010-03-09 |
Family
ID=40282306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010001363A MX2010001363A (es) | 2007-08-09 | 2008-08-01 | Peptidos inmunomoduladores. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8906844B2 (es) |
EP (1) | EP2203471A2 (es) |
JP (1) | JP2010535788A (es) |
KR (1) | KR20100040951A (es) |
CN (1) | CN101815723A (es) |
AU (1) | AU2008284047A1 (es) |
BR (1) | BRPI0814763A2 (es) |
CA (1) | CA2694824A1 (es) |
EA (1) | EA201070231A1 (es) |
MX (1) | MX2010001363A (es) |
TW (1) | TW200911289A (es) |
WO (1) | WO2009020867A2 (es) |
ZA (1) | ZA201001451B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200745163A (en) | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
MX2010001363A (es) | 2007-08-09 | 2010-03-09 | Syntonix Pharmaceuticals Inc | Peptidos inmunomoduladores. |
CN102584982B (zh) * | 2012-02-10 | 2014-02-05 | 深圳翰宇药业股份有限公司 | 一种纯化固相合成利拉鲁肽粗肽的方法 |
GB201208370D0 (en) | 2012-05-14 | 2012-06-27 | Ucb Pharma Sa | Antibodies |
ZA201506407B (en) * | 2013-03-15 | 2018-11-28 | Affibody Ab | New polypeptides |
BR112015021730A2 (pt) | 2013-03-15 | 2017-08-29 | Affibody Ab | POLIPEPTÍDEO DE LIGAÇÃO AO FcRn, PROTEÍNA DE FUSÃO OU CONJUGADO, POLINUCLEOTÍDEO QUE CODIFICA UM POLIPEPTÍDEO, COMPOSIÇÃO, POLIPEPTÍDEO DE LIGAÇÃO AO FcRn, PROTEÍNA DE FUSÃO OU CONJUGADO E POLIPEPTÍDEO DE LIGAÇÃO AO FcRn, PROTEÍNA DE FUSÃO, CONJUGADO OU COMPOSIÇÃO PARA USO |
GB201320066D0 (en) | 2013-11-13 | 2013-12-25 | Ucb Pharma Sa | Biological products |
CA2945945C (en) | 2014-04-15 | 2023-10-03 | The Regents Of The University Of California | Bi-terminal pegylated integrin-binding peptides and methods of use thereof |
MX2017003459A (es) | 2014-09-17 | 2017-10-31 | Affibody Ab | Polipeptidos novedosos. |
JP7239202B2 (ja) * | 2017-11-27 | 2023-03-14 | ザ・ユニバーシティ・オブ・ホンコン | Yeats阻害剤およびその使用方法 |
WO2019183556A1 (en) * | 2018-03-23 | 2019-09-26 | University Of Kansas | Cyclic tetrapeptide analogs |
CN115645537A (zh) * | 2022-10-25 | 2023-01-31 | 成都臻拓医药科技有限公司 | FcRn抑制剂在制备抑制自身免疫性疾病复发的药物中的用途 |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
US4215051A (en) | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
DE3572982D1 (en) | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
US5981216A (en) | 1985-04-01 | 1999-11-09 | Alusuisse Holdings A.G. | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
EP0206448B1 (en) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hemoglobin combined with a poly(alkylene oxide) |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US5888512A (en) | 1987-01-30 | 1999-03-30 | Board Of Trustees Of The Leland Stanford Junior University | Lymphocyte activity regulation by HLA peptides |
CA2006596C (en) | 1988-12-22 | 2000-09-05 | Rika Ishikawa | Chemically-modified g-csf |
EP0394827A1 (en) | 1989-04-26 | 1990-10-31 | F. Hoffmann-La Roche Ag | Chimaeric CD4-immunoglobulin polypeptides |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US5677440A (en) | 1990-07-16 | 1997-10-14 | Howard Florey Institute Of Experimental Physiology And Medicine | Oligonucleotide-polyamide conjugates |
EP0513332A4 (en) | 1990-11-14 | 1993-03-17 | Cargill, Incorporated | Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
US5252714A (en) | 1990-11-28 | 1993-10-12 | The University Of Alabama In Huntsville | Preparation and use of polyethylene glycol propionaldehyde |
CA2288429C (en) | 1991-03-15 | 2006-04-25 | Synergen, Inc. | Pegylation of polypeptides |
US5623053A (en) | 1992-01-10 | 1997-04-22 | California Institute Of Technology | Soluble mammal-derived Fc receptor which binds at a pH ranging from about 5.5 to 6.5 and releases at a pH ranging from about 7.5 to 8.5 |
US5326856A (en) | 1992-04-09 | 1994-07-05 | Cytogen Corporation | Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
US5449761A (en) | 1993-09-28 | 1995-09-12 | Cytogen Corporation | Metal-binding targeted polypeptide constructs |
US6030613A (en) | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US6086875A (en) | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
HUP9901005A2 (hu) | 1995-09-26 | 1999-07-28 | University Of Washington | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B |
US7141676B1 (en) | 1996-02-08 | 2006-11-28 | University Of Washington | Water soluble multi-biotin-containing compounds |
WO1997043316A1 (en) | 1996-05-10 | 1997-11-20 | Beth Israel Deaconess Medical Center, Inc. | Physiologically active molecules with extended half-lives and methods of using same |
WO1998023289A1 (en) | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
US6128119A (en) | 1997-01-10 | 2000-10-03 | Asahi Kogaku Kogyo Kabushiki Kaisha | Beam shaping optical system |
PT959905E (pt) | 1997-01-21 | 2010-02-05 | Sanofi Pasteur | Conjugados de polissacárido e péptido |
US6281331B1 (en) | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
US6362371B1 (en) | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US6197526B1 (en) | 1999-01-04 | 2001-03-06 | Dyax Corp. | Polypeptides for binding human factor VIII and fragments of human factor VIII |
US20040241727A1 (en) | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
US7473528B2 (en) | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US6469136B1 (en) | 1999-07-07 | 2002-10-22 | Trimeris, Inc. | Methods and composition for peptide synthesis |
WO2001083525A2 (en) | 2000-05-03 | 2001-11-08 | Amgen Inc. | Modified peptides, comprising an fc domain, as therapeutic agents |
PT2281843T (pt) | 2000-06-16 | 2017-01-02 | Human Genome Sciences Inc | Anticorpos que se ligam imunoespecificamente a blys |
US6992234B2 (en) | 2000-11-06 | 2006-01-31 | The Jackson Laboratory | FcRn-based therapeutics for the treatment of auto-immune disorders |
JP2002214374A (ja) | 2001-01-15 | 2002-07-31 | Agilent Technologies Japan Ltd | 位置決め装置及び位置決め方法 |
US6867283B2 (en) | 2001-05-16 | 2005-03-15 | Technion Research & Development Foundation Ltd. | Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells |
US6900292B2 (en) | 2001-08-17 | 2005-05-31 | Lee-Hwei K. Sun | Fc fusion proteins of human erythropoietin with increased biological activities |
WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
NZ541504A (en) | 2002-11-13 | 2009-04-30 | Uab Research Foundation | Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use |
US20050009136A1 (en) | 2003-02-19 | 2005-01-13 | Dyax Corporation | PAPP-A ligands |
US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
WO2004100882A2 (en) | 2003-05-06 | 2004-11-25 | Syntonix Pharmaceuticals, Inc. | Inhibition of drug binding to serum albumin |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
WO2004108885A2 (en) | 2003-05-06 | 2004-12-16 | Syntonix Pharmaceuticals, Inc. | Fc chimeric proteins with anti-hiv drugs |
JP2007501847A (ja) | 2003-08-08 | 2007-02-01 | ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク | 自己/同種免疫状態の治療用抗FcRn抗体 |
US7662928B2 (en) | 2003-08-08 | 2010-02-16 | The Research Foundation Of State University Of New York | Anti-FcRn antibodies for treatment of auto/allo immune conditions |
US7232805B2 (en) | 2003-09-10 | 2007-06-19 | Inflabloc Pharmaceuticals, Inc. | Cobalamin conjugates for anti-tumor therapy |
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
US7176185B2 (en) | 2003-11-25 | 2007-02-13 | Tsrl, Inc. | Short peptide carrier system for cellular delivery of agent |
DE102004031579B4 (de) | 2004-06-29 | 2012-12-27 | Forschungsverbund Berlin E.V. | Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung |
WO2006108052A2 (en) | 2005-04-06 | 2006-10-12 | Genzyme Corporation | Peg and polysialic lysosomal enzyme conjugates via acid labile linkers for therapeutic targeting |
TW200745163A (en) * | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
MX2010001363A (es) | 2007-08-09 | 2010-03-09 | Syntonix Pharmaceuticals Inc | Peptidos inmunomoduladores. |
US20100048488A1 (en) | 2008-08-01 | 2010-02-25 | Syntonix Pharmaceuticals, Inc. | Immunomodulatory peptides |
-
2008
- 2008-08-01 MX MX2010001363A patent/MX2010001363A/es unknown
- 2008-08-01 JP JP2010520228A patent/JP2010535788A/ja not_active Withdrawn
- 2008-08-01 US US12/671,883 patent/US8906844B2/en not_active Expired - Fee Related
- 2008-08-01 CN CN200880101801A patent/CN101815723A/zh active Pending
- 2008-08-01 BR BRPI0814763-9A2A patent/BRPI0814763A2/pt not_active Application Discontinuation
- 2008-08-01 TW TW097129265A patent/TW200911289A/zh unknown
- 2008-08-01 EA EA201070231A patent/EA201070231A1/ru unknown
- 2008-08-01 CA CA2694824A patent/CA2694824A1/en not_active Abandoned
- 2008-08-01 KR KR1020107004754A patent/KR20100040951A/ko not_active Application Discontinuation
- 2008-08-01 WO PCT/US2008/071960 patent/WO2009020867A2/en active Application Filing
- 2008-08-01 AU AU2008284047A patent/AU2008284047A1/en not_active Abandoned
- 2008-08-01 EP EP08827004A patent/EP2203471A2/en not_active Withdrawn
-
2010
- 2010-02-26 ZA ZA2010/01451A patent/ZA201001451B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008284047A1 (en) | 2009-02-12 |
EA201070231A1 (ru) | 2010-10-29 |
CA2694824A1 (en) | 2009-02-12 |
TW200911289A (en) | 2009-03-16 |
WO2009020867A2 (en) | 2009-02-12 |
BRPI0814763A2 (pt) | 2015-03-03 |
US8906844B2 (en) | 2014-12-09 |
EP2203471A2 (en) | 2010-07-07 |
WO2009020867A3 (en) | 2009-05-14 |
ZA201001451B (en) | 2011-08-31 |
JP2010535788A (ja) | 2010-11-25 |
US20110230639A1 (en) | 2011-09-22 |
KR20100040951A (ko) | 2010-04-21 |
CN101815723A (zh) | 2010-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010001363A (es) | Peptidos inmunomoduladores. | |
TW200745163A (en) | Peptides that block the binding of IgG to FcRn | |
PH12015500093A1 (en) | Il-17 binding proteins | |
WO2006118772A3 (en) | Fcrn antibodies and uses thereof | |
EP2937361A3 (en) | Fc variants with altered binding to fcRn | |
MY146664A (en) | Antibodies against human il-22 and uses therefor | |
WO2010033279A3 (en) | Antibodies with altered binding to fcrn and methods of using same | |
WO2010136311A3 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
NZ599875A (en) | Human il-23 antigen binding proteins | |
SG196839A1 (en) | Antibodies against fcrn and use thereof | |
EP2322557A3 (en) | Compositions and methods for treating proliferative disorders | |
WO2007042309A3 (en) | Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 | |
MX2009006471A (es) | Anticuerpo anti especifico de linfopoyetina estromal timica de diseño. | |
MX2008009886A (es) | Anticuerpos que enlazan par-2. | |
WO2008131451A3 (en) | Pva-paa hydrogels | |
MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
WO2008051797A3 (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases | |
WO2007100643A3 (en) | Methods of using antibodies against human il-22 | |
AU2009260320A8 (en) | Antibodies to IL-6 and their uses | |
WO2011094259A3 (en) | Cd127 binding proteins | |
WO2011004028A3 (en) | Tlr3 binding agents | |
WO2010045388A3 (en) | Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis | |
WO2009023267A3 (en) | Methods for modulating development and expansion of il-17 expressing cells | |
RS20080075A (en) | Aptamers that bind thrombin with high affinity | |
WO2010136483A3 (en) | Antigen-binding proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general |